These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 20560047)

  • 21. Novel techniques and targets in cardiovascular microRNA research.
    Dangwal S; Bang C; Thum T
    Cardiovasc Res; 2012 Mar; 93(4):545-54. PubMed ID: 22072632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.
    Nollet E; Hoymans VY; Van Craenenbroeck AH; Vrints CJ; Van Craenenbroeck EM
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H207-18. PubMed ID: 27208159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs as a therapeutic target for cardiovascular diseases.
    Mishra PK; Tyagi N; Kumar M; Tyagi SC
    J Cell Mol Med; 2009 Apr; 13(4):778-89. PubMed ID: 19320780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs and Endothelial (Dys) Function.
    Santulli G
    J Cell Physiol; 2016 Aug; 231(8):1638-44. PubMed ID: 26627535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases.
    Tyagi AC; Sen U; Mishra PK
    Curr Diabetes Rev; 2011 Nov; 7(6):367-76. PubMed ID: 21864292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of cardiovascular microRNA targetomes.
    Fiedler J; Gupta SK; Thum T
    J Mol Cell Cardiol; 2011 Nov; 51(5):674-81. PubMed ID: 21888912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in vascular biology and vascular disease.
    Zhang C
    J Cardiovasc Transl Res; 2010 Jun; 3(3):235-40. PubMed ID: 20560045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA and vascular cell movement.
    Yue J
    Adv Drug Deliv Rev; 2011 Jul; 63(8):616-22. PubMed ID: 21241758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micromanaging vascular biology: tiny microRNAs play big band.
    Sen CK; Gordillo GM; Khanna S; Roy S
    J Vasc Res; 2009; 46(6):527-40. PubMed ID: 19571573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA therapeutics in cardiovascular disease models.
    Dangwal S; Thum T
    Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular importance of the microRNA-23/27/24 family.
    Bang C; Fiedler J; Thum T
    Microcirculation; 2012 Apr; 19(3):208-14. PubMed ID: 22136461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Therapeutic Potential of microRNAs in Vascular Disease.
    Maegdefessel L
    Curr Vasc Pharmacol; 2015; 13(3):277-9. PubMed ID: 26156263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNAs: roles and clinical applications in vascular disease.
    Jamaluddin MS; Weakley SM; Zhang L; Kougias P; Lin PH; Yao Q; Chen C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):79-89. PubMed ID: 21171923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
    Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
    Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiRNAs in peripheral artery disease - something gripping this way comes.
    Kloos W; Vogel B; Blessing E
    Vasa; 2014 May; 43(3):163-70. PubMed ID: 24797047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unlocking the door to new therapies in cardiovascular disease: microRNAs hold the key.
    Nguyen MA; Karunakaran D; Rayner KJ
    Curr Cardiol Rep; 2014 Nov; 16(11):539. PubMed ID: 25303893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs: Biomarkers, Diagnostics, and Therapeutics.
    Huang W
    Methods Mol Biol; 2017; 1617():57-67. PubMed ID: 28540676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements.
    Poller W; Fechner H
    Curr Pharm Des; 2010; 16(20):2252-68. PubMed ID: 20459390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.